Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
lung cancer treatment
Jul 6, 2024, 12:06 |
Blog
Real world data on QTc prolongation with osimertinib
Stephen V Liu shared on X: "Real world data on QTc prolongation with osimertinib. 970 pts…
Jul 5, 2024, 13:40 |
Blog
Amy C. Moore: It's hard to even conceive of an advocacy world without Ivy Elkins
Amy C. Moore, VP, Global Engagement and Research Partnerships at LUNGevity Foundation, shared a post…
Jul 5, 2024, 10:25 |
Blog
Stephen V Liu: Important dates for thoracic oncologists
Stephen V Liu shared on X: "For all thoracic oncologists out there, keep these dates…
Jul 5, 2024, 06:54 |
Blog
Estela Rodriguez: Underreported toxicity of myopathy from EGFR TKIs
Estela Rodriguez shared a post by Stephen V Liu, on X: "Important to study under reported toxicity…
Jul 5, 2024, 05:47 |
Blog
Jill Feldman: I've lost a masssive piece of my heart with the loss of Ivy
Jill Feldman shared on X: "I've been steering clear of social media this past week as…
Jul 4, 2024, 08:41 |
Blog
Julie McCrossin: Exciting clinical innovation - FDA approved Adaptive Proton Therapy
Julie McCrossin, Broadcaster, Cancer Survivor and Community Educator, shared a post in LinkedIn: . "How…
Jul 2, 2024, 08:55 |
Blog
Mark Wildgust: Another incredible milestone for our JNJOncology team!
Mark Wildgust, Vice President, Global Medical Affairs, Oncology at The Janssen Pharmaceutical Companies of Johnson and…
Jul 1, 2024, 15:15 |
Blog
Cesar Perez: Increasing the Impact of Immunotherapy
Cesar Perez, Director of Drug Development at Lake Nona DDU of Florida Cancer Specialists and…
Jul 1, 2024, 15:01 |
Blog
Antonio Passaro: A significant milestone for the advancement and understanding of EGFR-mutated NSCLC
Antonio Passaro, shared a post on LinkedIn: "I am honored to have contributed, as investigator…
Jul 1, 2024, 03:08 |
Blog
Stephen V Liu: Phase III Adjuvant BR.31 study does not meet primary endpoint
Stephen V Liu shared on X: “Phase III ADJUVANT BR.31 study does not meet primary…
62
63
64
65
66
All:
857
Posts:
631 - 640
Agenus CEO Dr. Garo Armen Honored with WITSA Eminent Person 2024 Award for Cancer Immunotherapy Breakthrough
Vivek Subbiah: Key publications leading to Nobel Prize 2024, published in 1993
Dr. Zainab Shinkafi-Bagudu: Advocating for Equity in Cancer Care - UICC Presidential Candidacy
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6
ASTRO24: 15 Posts Not To Miss From Day 4
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube